UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 328

Sortiert nach

L'ultrasonographie à haute fréquence et le celluscore : un progrès dans l'évaluation objective du phénomène de cellulite

Annales de chirurgie plastique et esthétique, 2004-08, Vol.49 (4), p.387-395

2004

Link zum Volltext

Verfügbarkeit prüfen

Dépistage précoce de la sarcopénie du sujet âgé en services de soins aigus

Nutrition clinique et métabolisme, 2020-04, Vol.34 (1), p.44-44

2020

Link zum Volltext

Verfügbarkeit prüfen

High frequency ultrasonography and celluscore: an improvement in the objective evaluation of cellulite phenomenon

Annales de chirurgie plastique et esthétique, 2004-08, Vol.49 (4), p.387-395

2004

Link zum Volltext

Verfügbarkeit prüfen

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3808-3816

2001

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4265-4274

2005

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group

European journal of cancer (1990), 2010-05, Vol.46 (8), p.1296-1316

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

The lancet oncology, 2018-01, Vol.19 (1), p.27-39

2018

Link zum Volltext

Verfügbarkeit prüfen

Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment

Journal of clinical oncology, 2002-08, Vol.20 (16), p.3396-3403

2002

Link zum Volltext

Verfügbarkeit prüfen

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005

Annals of oncology, 2005-10, Vol.16 (10), p.1569-1583

2005

Link zum Volltext

Verfügbarkeit prüfen

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Annals of oncology, 2011-10, Vol.22 (10), p.2201-2207

2011

Link zum Volltext

Verfügbarkeit prüfen

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Journal of clinical oncology, 2002-06, Vol.20 (12), p.2812-2823

2002

Link zum Volltext

Verfügbarkeit prüfen

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The Lancet (British edition), 2011-08, Vol.378 (9793), p.771-784

2011

Link zum Volltext

Verfügbarkeit prüfen

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

The Lancet (British edition), 2011-11, Vol.378 (9804), p.1707-1716

2011

Link zum Volltext

Verfügbarkeit prüfen

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3748-3757

2000

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

The New England journal of medicine, 2005-12, Vol.353 (26), p.2747-2757

2005

Link zum Volltext

Verfügbarkeit prüfen

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

Annals of oncology, 2009-08, Vol.20 (8), p.1319-1329

2009

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the bio-optical anomaly and diurnal variability of particulate matter, as seen from scattering and backscattering coefficients, in ultra-oligotrophic eddies of the Mediterranean Sea

Biogeosciences, 2011-01, Vol.8 (11), p.3295-3317

2011

Link zum Volltext

Verfügbarkeit prüfen

Proust aux revues : La naissance de Miss Sacripant

L'Esprit créateur, 2022-10, Vol.62 (3), p.10-24

Mauriac Dyer, Nathalie

2022

Link zum Volltext

Verfügbarkeit prüfen

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

The New England journal of medicine, 2009-08, Vol.361 (8), p.766-776

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

Annals of oncology, 2001-09, Vol.12 (9), p.1247-1254

2001

Link zum Volltext

Verfügbarkeit prüfen

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

Annals of oncology, 2001-11, Vol.12 (11), p.1527-1532

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 328

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(265)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(22)
Annals Of Oncology
(19)
European Journal Of Cancer
(19)
Revue Des Deux Mondes
(16)
Bulletin Du Cancer
(15)
British Journal Of Cancer
(9)
Cancer Research
(9)
Encéphale
(8)
La Presse Medicale
(8)
Breast Cancer Research And Treatment
(7)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

L'ultrasonographie à haute fréquence et le celluscore : un progrès dans l'évaluation objective du phénomène de cellulite

Dépistage précoce de la sarcopénie du sujet âgé en services de soins aigus

High frequency ultrasonography and celluscore: an improvement in the objective evaluation of cellulite phenomenon

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Characterization of the bio-optical anomaly and diurnal variability of particulate matter, as seen from scattering and backscattering coefficients, in ultra-oligotrophic eddies of the Mediterranean Sea

Proust aux revues : La naissance de Miss Sacripant

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

Suchergebnisse filtern